GlassScriptPhysician profile
Frances Anerousis
NPI 1073723896
$1,123.26
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $233 · 2021: $343 · 2022: $324 · 2023: $37.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $37.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $37.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $215.73 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $130.71 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $83.70 | 2019-2022 | |
| Janssen Biotech, INC. | $78.28 | 2020-2023 | Rybrevant |
| Emd Serono, INC. | $56.22 | 2021-2022 | |
| Incyte Corporation | $54.63 | 2019-2022 | |
| Seagen INC. | $51.29 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $50.71 | 2021-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $40.46 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.89 | 2022-2023 | Alunbrig |
| Amgen INC. | $32.83 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $29.03 | 2020-2021 | |
| Abbvie INC. | $28.84 | 2019-2022 | |
| Pfizer INC. | $28.79 | 2019 | |
| Alexion Pharmaceuticals, INC. | $26.69 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tg Therapeutics, INC. | $25.89 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $20.00 | 2021 | |
| Advanced Accelerator Applications | $19.33 | 2020 | |
| Servier Pharmaceuticals LLC | $15.61 | 2022 | |
| Sobi, INC | $14.92 | 2022 | |
| Sun Pharmaceutical Industries INC. | $14.46 | 2019 | |
| Beigene USA, INC. | $14.31 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $14.25 | 2022 | |
| Amarin Pharma, INC. | $14.11 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.11 | 2019 | |
| Jazz Pharmaceuticals INC. | $13.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frances Anerousis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.